Evidence map›Paper›PMID 37266969›Full record

SynthesisCardiovascular journal of Africa

Hypertension treatment in sub-Saharan Africa: a systematic review.

Pauline Cavagna, Céline Leplay, Roland N'Guetta, Kouadio Euloge Kramoh, Ibrahima Bara Diop, Dadhi M Balde, Jean Bruno Mipinda, Michel Azizi, Xavier Jouven, Marie Antignac

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Cardiovascular journal of Africa. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
34.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Pauline CavagnaDepartment of Pharmacy, Pitié Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France; Université Paris Cité, Inserm, PARCC, Paris, France. Email: pauline.cavagna@aphp.fr.
Céline LeplayDepartment of Pharmacy, Pitié Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France.
Roland N'GuettaInstitute of Cardiology of Abidjan, Abidjan, Ivory Coast.
Kouadio Euloge KramohInstitute of Cardiology of Abidjan, Abidjan, Ivory Coast.
Ibrahima Bara DiopCardiology Department, University Hospital of Fann, Dakar, Senegal.
Dadhi M BaldeDepartment of Cardiology, University Hospital of Conakry, Guinea.
Jean Bruno MipindaUniversity Hospital of Libreville, Libreville, Gabon.
Michel AziziCardiovascular Epidemiology Department, University of Paris, Paris, France; Hypertension Unit, European Georges Pompidou Hospital, and National Institute of Health and Medical Research, Clinical Research Centre, Paris, France.
Xavier JouvenUniversité Paris Cité, Inserm, PARCC, Paris, France; Cardiovascular Epidemiology Department, University of Paris, Paris, France; Cardiology Department, European Georges Pompidou Hospital, Paris, France.
Marie AntignacDepartment of Pharmacy, Pitié Salpêtrière Hospital, AP-HP Sorbonne University, Paris, France; Université Paris Cité, Inserm, PARCC, Paris, France.
Institut Universitaire d'Abidjan · CICentre Hospitalier National Universitaire de Fann · SNGamal Abdel Nasser University of Conakry · GNLibreville Hospital · GA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sub-Saharan Africa (SSA) faces the highest rate of hypertension worldwide. Blood pressure (BP) control rests on the association of lifestyle modification and antihypertensive medicines. We aimed to systematically review antihypertensive strategies implemented in SSA to achieve BP control. A systematic search beginning in 2003 was performed in MEDLINE, COCHRANE and EMBASE. We included only original and observational studies in SSA countries. Thirty studies were included from 11 countries. No study was multinational. The number of patients varied from 111 to 897 (median: 294; IQR: 192-478). Overall, 21% of patients received monotherapy, 42.6% two-drug and 26.6% three-drug combinations. Out of all the strategies, renin-angiotensin system (RAS) blockers were mostly prescribed, followed by diuretics and calcium channel blockers. In monotherapy, RAS blockers were the first to be prescribed. Only 10 articles described antihypertensive strategies beyond triple combinations. BP control was highly variable (range: 16.4 to 61.2%). Multicentre studies performed in several SSA countries are needed to ensure international guidelines actually do improve outcomes in SSA.

Indexed as

Antihypertensive AgentsBlood PressureHypertensionAfrica South of the SaharaCalcium Channel BlockersDiureticsDrug Therapy, CombinationHumansTreatment OutcomeAntihypertensive AgentsCalcium Channel BlockersDiureticsantihypertensive medicationsdeveloping countrieshypertensionsub‐Saharan Africa

Identifiers

PMID37266969
PMCPMC11040475
OpenAlexW4379095008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.